ArticleFrontiers in oncology2022

Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study.

Mark M Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.